Several trials have shown that hypertensive patients whose blood pressure (BP) is brought
under control (< 140/90 mmHg) have significantly fewer cardiovascular events than patients …

This double-blind, placebo-controlled, four-way balanced design crossover study included
hypertensive patients aged 60–85 years with mean office-measured sitting systolic blood …

Inadequate control of blood pressure markedly increases the risk of cardiovascular mortality
and morbidity associated with hypertension. Subsequently, official guidelines recommend …

Background: Irrespective of their clinical relevance, side effects cannot be considered a
negligible problem in antihypertensive therapy. The aim of this trial was to evaluate the …

Hypertension is the most important preventable cause of premature death in the developed
countries, and the benefits of antihypertensive drugs regarding cardiovascular morbidity and …

This review presents the evidence on the benefits of fixed-dose combination therapy for
arterial hypertension management. The focus is on the combination of a third-generation …

Hypertension is an important risk factor for premature death as it increases the probability of
stroke, myocardial infarction, and heart failure. Antihypertensive drugs can decrease …

Although many efforts paid to prevention and treatment of the hypertension, mortality and
morbidity hypertension-related is still unacceptably high. This is largely due to the difficulty in …

Methods Two groups of hypertensive patients (G1: aged< 65, G2: aged> or= 65) entered an
open study conducted over 56 days. All received lercanidipine 10 mg/d (monotherapy or …

Although achieving blood pressure (BP) control is critical to improve cardiovascular
prognosis in hypertensive patients, many of them fail to achieve BP goals. The majority of …